BioCryst Pharmaceuticals | 营业利润

Operating Profit 更改 日
Gilead Sciences USD 1.61B 1.01B 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



BioCryst Pharmaceuticals 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.